TVGN (Tevogen Bio Holdings) Long-Term Capital Lease Obligation : $0.04 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Long-Term Capital Lease Obligation?

Tevogen Bio Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.04 Mil.

Tevogen Bio Holdings's quarterly Long-Term Capital Lease Obligation declined from Mar. 2024 ($0.17 Mil) to Jun. 2024 ($0.10 Mil) and declined from Jun. 2024 ($0.10 Mil) to Sep. 2024 ($0.04 Mil).

Tevogen Bio Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for Tevogen Bio Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Long-Term Capital Lease Obligation Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Tevogen Bio Holdings Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial					-	-	0.17	0.10	0.04

Tevogen Bio Holdings (NAS:TVGN) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Tevogen Bio Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.